The First 2 Years of the European Medicines Agency's Policy on Access to Documents: Secret No Longer

被引：23
|
作者：
Doshi, Peter [2 ]
Jefferson, Tom [1 ]
机构：
[1] Cochrane Collaborat, Rome, Italy
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
来源：
JAMA INTERNAL MEDICINE | 2013年 / 173卷 / 05期
关键词：
D O I：
10.1001/jamainternmed.2013.3838
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：380 / 382
页数：4
相关论文
共 50 条
  • [1] Transparency Interrupted: The Curtailment of the European Medicines Agency's Policy on Access to Documents
    Doshi, Peter
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (21)
  • [2] European Medicines Agency widens access to its documents
    Watson, Rory
    [J]. BRITISH MEDICAL JOURNAL, 2010, 341
  • [3] Drug Policy for an Aging Population - The European Medicines Agency's Geriatric Medicines Strategy
    Cerreta, Francesca
    Eichler, Hans-Georg
    Rasi, Guido
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (21): : 1972 - 1974
  • [4] European Medicines Agency's Priority Medicines Scheme at 2 Years: An Evaluation of Clinical Studies Supporting Eligible Drugs
    Neez, Emilie
    Hwang, Thomas J.
    Sahoo, Samali Anova
    Naci, Huseyin
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (03) : 541 - 552
  • [5] The European Medicines Agency's approval of new medicines for type 2 diabetes
    Blind, Eberhard
    Janssen, Heidi
    Dunder, Kristina
    de Graeff, Pieter A.
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (09): : 2059 - 2063
  • [6] European Medicines Agency approves first malaria vaccine
    Hawkes, Nigel
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [7] Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years
    A. Ceci
    M. Felisi
    P. Baiardi
    F. Bonifazi
    M. Catapano
    C. Giaquinto
    A. Nicolosi
    M. Sturkenboom
    A. Neubert
    I. Wong
    [J]. European Journal of Clinical Pharmacology, 2006, 62 : 947 - 952
  • [8] Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years
    Ceci, A.
    Felisi, M.
    Baiardi, P.
    Bonifazi, F.
    Catapano, M.
    Giaquinto, C.
    Nicolosi, A.
    Sturkenboom, M.
    Neubert, A.
    Wong, I.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (11) : 947 - 952
  • [9] The European Medicines Agency facilitates access to medicines in low- and middle-income countries
    Cavaller Bellaubi, Maria
    Harvey Allchurch, Martin
    Lagalice, Clement
    Saint-Raymond, Agnes
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (03) : 321 - 325
  • [10] European Medicines Agency changes policy on clinical trial data publication
    Watson, Rory
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
12345